International Conference On Cancer Research & Treatment 2019
THEME: MISSION AND INNOVATION TO ERADICATE CANCER
Date and Venue
25 - 26 Mar, 2019
Bangkok, Thailand
Keynote Speakers
Dr. Alessandro Testori
Doctor in Medicine and Surgery, Milano University.
Prof. Rony Seger
Professor in Biological Regulation, in the Weizmann Institute of Science, Rehovot, Israel
Prof. Altaf A. Wani
Professor in the Department of Radiology and the Department of Cellular and Molecular Biology at Ohio State University (OSU).
Dr. Jurgen Lademann
Director of the Center of Experimental and Applied Cutaneous Physiology at the Department of Dermatology.
Krishnan Suthanthiran
He established Best Medical International (BMI) in 1977. His single goal is, to be the best in everything.
Meet Our Speakers
Greet and meet our Speakers of International Conference on Cancer Research & Treatment 2019
Dr. Jurgen LademannSenior Researcher
Prof. Dr. Jurgen Lademann
Dr. Jurgen Lademann serves as Director of the Center of Experimental and Applied Cutaneous Physiology (CEACP), at the Department of Dermatology, Venerology and Allergology of Charite Berlin. Dr. Lademann is a leading expert on the non-invasive measurement of biomarkers in human skin. He is editor of the international journal "Skin Pharmacology and Applied Skin Physiology," and board member of the German Federal Institute of Risk Assessment, Berlin, Germany. He is an internationally recognized researcher who is focused on the interface between dermatology, pharmacology and biophysics. Originally a physicist, he has been head of the department of “Experimental and Applied Physiology of the Skin” at the Hospital for Dermatology, Venereology and Allergology, at the Charité – Universitätsmedizin Berlin since 1996. He was appointed professor for dermatology in 2001.
Prof. Gennaro CilibertoProfessor of Molecular Biology
Prof. Gennaro Ciliberto
Full Professor of Molecular Biology, University of Catanzaro “Magna Graecia,” since 1995. He has over 25 years of research management experience. In particular, his experience at Merck Sharp and Dohme research centre IRBM P. Angeletti in Pomezia (Rome) from 1991-2009 included responsibilities for several early drug discovery programs (target identification to phase I clinical trials), membership of several decision-making committees, and Site Head and Managing Director for 200 employees (2006-2009).
In November 2009, he co-founded Takis s.r.l., a spin-off of the IRBM P. Angeletti, with the main focus on research and development in Oncology. In March 2012, he was appointed Scientific Director of IRCSS Istituto Nazionale Tumori, Senatore “G. Pascale” Napoli. He has over 200 publications in the areas of cancer stem cell therapy, cancer vaccines, somatic gene therapy, structure and function of cytokines (e.g. IL6), and transcriptional control of acute phase response.
He has acquired significant experience in the field of Technology Transfer as evidenced by his presence as Co-inventor in more than 25 international patents. Referee and member of the editorial board of numerous international scientific journals, and editor of a Molecular Biology textbook for university students.
Prof. Rony SegerProfessor in Biological Regulation
Prof. Rony Seger
Rony Seger is a professor in the Department of Biological Regulation, the Weizmann Institute of Science, Rehovot, Israel. He completed his doctorate at the Weizmann Institute at 1990 and moved to postdoc training with the late Prof. Krebs at Washington University, USA. At 1994 he re-joined the Weizmann Institute as a group leader.
Over the years Dr. Seger contributed significantly to the field of signal transduction, and recently to the stimulated nuclear translocation of MAPKs. Dr. Seger published more than 200 papers, supervised more than 100 students or postdoctoral fellows, and received several prizes including the Teva research prize.
Dr Trinanjan BasuConsultant Radiation Oncologist
Dr Trinanjan Basu
MBBS and MD (Radiation Oncology) from Calcutta University. Expert in IGRT, VMAT, SRS, and SBRT
Dr Trinanjan Basu has completed both his MBBS and MD (Radiation Oncology) from Calcutta University in 2010. He then did senior residency from Tata Memorial Hospital, Mumbai for 2.5 years. He has been working as the radiation oncologist for last 8 years and has the training and expertise in all available technologies like IGRT, VMAT, SRS, and SBRT. He has worked with state of the art radiotherapy technologies like Tomotherapy and Cyberknife. Currently, he is working as consultant radiation oncologist in Mumbai and head and neck cancer, brain tumors, SBRT in extracranial diseases like lung, pancreas, sarcomas, and quality of life issues are very close to his heart.
He has more than 25 publications in indexed peer-reviewed journals, few book chapters, reviewer for International journals and Editorial committee member of leading publishing house. He has received several ESMO and ESTRO grants. He is a member of the International Geriatric radiotherapy group and was an observer at Institute Gustave Roussy, Paris. He is also a visiting fellow at National Cancer Centre, Singapore and was awarded the 1st ever Foundation of leadership in Radiation Oncology certificate under ESTRO-CARO-RANZCR.
He has more than 25 publications in indexed peer-reviewed journals, few book chapters, reviewer for International journals and Editorial committee member of leading publishing house. He has received several ESMO and ESTRO grants. He is a member of the International Geriatric radiotherapy group and was an observer at Institute Gustave Roussy, Paris. He is also a visiting fellow at National Cancer Centre, Singapore and was awarded the 1st ever Foundation of leadership in Radiation Oncology certificate under ESTRO-CARO-RANZCR.
Krishnan SuthanthiranFounder of TeamBest Companies
Krishnan Suthanthiran
Named International Man of the Year by the Multi-Ethnic Advisory Task Force (MEATF. President & Founder of TeamBest Companies, is an entrepreneur engaged in multiple business ventures in Medical, Energy, Entertainment, and Real Estate industries and holds the role of president for multiple companies globally. Having lost his father to cancer while he was an undergraduate student, he has dedicated his career to cancer research and treatment. TeamBest products are used to treat millions of cancer patients every day globally.
Dr Suvadip ChakrabartiConsultant Surgical Oncologist
Dr Suvadip Chakrabarti
Dr Suvadip Chakrabarti has completed his MS (General Surgery) at the age of 28 years from Texas DY Patil University, Navi Mumbai and MCh (Surgical Oncology) from DAVV University, Madhya Pradesh, India.
He is the Consultant Surgical Oncologist at Ruby Cancer Center, Kolkata India, a premier Cancer Centre. He has published more than 10 papers in reputed journals and has been serving as an editorial board member at Advances in Modern Oncology Research and Current Updates in Surgical Oncology. (Up to 100 words).
Prof. Altaf A. Wani Ph.D.Professor
Prof. Altaf A. Wani
Professor in the Department of Radiology and the Department of Cellular and Molecular Biology at Ohio State University (OSU).
Altaf A. Wani, Ph.D. is a professor in the Department of Radiology and the Department of Cellular and Molecular Biology at Ohio State University (OSU). He is a member of Molecular Carcinogenesis and Chemoprevention program of the James Cancer Hospital and Research Institute. Dr. Wani is the Director of Molecular Carcinogenesis Laboratory and conducts Basic Cancer research in the area of DNA damage and repair.
He is a Graduate Studies Committee member of the Ohio State Biochemistry Program and member of the Integrated Biomedical Graduate Program. He serves on the Appointments, Tenure and Promotion Committee of the OSU College of Medicine and Public Health. He represents his department at the University Faculty Council and Senate.
Neeraj JainAssociate Prof
Dr. Neeraj Jain
Dr Neeraj Jain is Associate Prof Radiation Oncology at Sri Guru Ram Das University Of Health Sciences Amritsar. He is eminent Radiation Oncologist and participated in numerous national and international conferences and presented papers. He is Vice Chairman of Indian College of Radiation Oncologists (ICRO). ICRO is an academic wing of AROI i.e. Association of Radiation Oncologists of India. He is well versed in modern Radiotherapy techniques.
Dr N. C. Tolga EmreAssociate Professor
Dr N. C. Tolga Emre
Associate professor and Group Leader, Laboratory of Genome Regulation, TurkeyHe received his doctoral degree from the University of Pennsylvania in 2005 and did postdoctoral work at US National Institutes of Health. Dr. Emre is a recipient of 2013 Young Scientist award from Science Academy Foundation of Turkey.
He is a faculty at Boğaziçi University’s Department of Molecular Biology & Genetics in Istanbul/Turkey since 2011 and currently an associate professor and group leader at the Laboratory of Genome Regulation, Turkey. Dr. Emre’s research focuses on gene regulatory mechanisms, especially epigenetic chromatin modifications and transcription factors in cancers. His research has been funded by grants from European Commission, European Molecular Biology Organization, Scientific and Technological Research Council of Turkey and Boğaziçi University.
Thomas LaddExecutive Director at Radiating Hope
Dr. Thomas Ladd
Executive Director at Radiating Hope
Tom is passionate about helping others and has actively served youth and communities in Thailand, Maryland, Utah as well as his current home in Jacksonville, Florida. He was born and raised in the Washington D.C area and graduated from Brigham Young University with a degree in International Relations.
His experiences and his volunteer work have honed his skills in business development, project management, and strengthening communities, which he now applies to furthering the work of Radiating Hope. Having personally lost loved ones to cancer, Tom is committed to helping cancer patients worldwide gain access to treatments and improved cancer care. In his free time, Tom loves playing golf, fishing, kayaking, stand-up paddle boarding, and indoor climbing with his family.
Dr. Alessandro TestoriDoctor in Medicine and Surgery
Dr. Alessandro Testori,
Doctor in Medicine and Surgery, Milano University
Specialization in General Surgery, Milano University. Working in multicentric Clinical trials according to ICH-GCP since 1994.
The Principal investigator of more than 70 clinical trials. Editorial Board member of the Melanoma Section of the Annals of Surgical Oncology (official journal of the Society of Surgical Oncology.
Member of the board of International society of sentinel node, Sentinel Node Oncology Foundation, Melanoma World society.
Prof. Sehmus ErtopHematology Specialist
Prof. Sehmus Ertop
Hematology Specialist
Prof.Dr.Sehmus Ertop is working at Zonguldak Bulent Ecevit University, School of Medicine, Department of Hematology, Turkey and is currently General Secretary of Hematology Specialist association in Turkey. In addition, he is also the Scientific Secretary of IX. International Euroasian Hematology Oncology Congress.
Dr. Richard J. AblinProfessor, Department of Pathology
Dr. Richard J. Ablin
Professor, Department of Pathology,
University of Arizona College of Medicine, Arizona Cancer Center
Dr. Richard J. Ablin is Professor, Department of Pathology, University of Arizona College of Medicine, Arizona Cancer Center and BIO5 Institute and President, Robert Benjamin Ablin Foundation for Cancer Research, founded in memory of his father, since 1979. Dr. Ablin received his Ph.D. in Microbiology from SUNY at Buffalo in 1967 and continued his training in immunology as a USPHS Postdoctoral Fellow at the Medical School under the late renowned Distinguished Professor Ernest Witebsky.
Dr. Ablin is the recipient of a D.Sc., honoris causa, from Lake Forest College, his undergraduate alma mater, and a Doctor is Honoris Causa from the “Carol Davila” University of Medicine and Pharmacy Bucharest. Dr. Ablin discovered prostate-specific antigen (PSA) in 1970, which led to the development of the PSA test, and was a nominee for the Lasker Award in 1997, he is the author of the recent book: The Great Prostate Hoax: How Big Medicine Hijacked the PSA Test and Caused a Public Health Disaster.
Dr. Ablin is the recipient of a D.Sc., honoris causa, from Lake Forest College, his undergraduate alma mater, and a Doctor is Honoris Causa from the “Carol Davila” University of Medicine and Pharmacy Bucharest. Dr. Ablin discovered prostate-specific antigen (PSA) in 1970, which led to the development of the PSA test, and was a nominee for the Lasker Award in 1997, he is the author of the recent book: The Great Prostate Hoax: How Big Medicine Hijacked the PSA Test and Caused a Public Health Disaster.
Dr. Jesper NylandstedGroup Leader
Dr. Jesper Nylandsted
Group Leader
Danish Cancer Society Research Center in Copenhagen
Dr. Jesper Nylandsted is Group Leader at the Danish Cancer Society Research Center in Copenhagen. His work focuses on alternative death pathways and repair mechanisms in cancer cells and novel approaches to target these processes. Using biophysical methods and live cell imaging, his group has revealed fundamental processes in cell death signaling and plasma membrane repair mechanisms of cancer cells.
Prof. Wen-Sen LeeProfessor
Prof. Wen-Sen Lee
Department of Physiology, Graduate Institute of Medical Sciences
Taipei Medical University
Wen-Sen Lee has completed his Ph.D. at the age of 34 years from the University of Pittsburgh and postdoctoral studies from Harvard Medical School. He is a professor at Taipei Medical University, Taiwan. He has published more than 130 papers that have been cited over 8,000 times, and his publication H-index is 50 and has been serving as an editorial board member of reputed Journals.
Prof. Shyng-Shiou F. YuanDirector
Prof. Shyng-Shiou F. Yuan
Kaohsiung Medical University, Taiwan
Professor Shyng-Shiou F. Yuan is currently the Director of Translational Research Center (TRC) and Chief of Department of Medical Research at Kaohsiung Medical University Hospital (KMUH), Kaohsiung Medical University (KMU), Taiwan. He is also an adjunct professor at Institute of Biomedical Science, National Sun Yat-sen University. He has published more than 100 SCI papers, mostly on cancer-related basic, translational and clinical studies. He is a recognized expert in exploring the roles of DNA repair proteins and obesity-related cytokines in human cancers, especially breast cancer, oral cancer, and lung cancers. Furthermore, he is also recognized as an expert in the development of anti-cancer compounds originated from natural products or through total synthesis in the laboratory.
After receiving the Ph.D. degree in Molecular Medicine from the University of Texas in 1998, he started his carrier at KMU. In 2004, he was recruited to E-Da Hospital and worked as Chief of Obstetrics&Gynecology Department and became a full professor at I-Shou University at 2007. At 2013, he was recruited by Kaohsiung Medical UniversityHospital to establish a research center focusing on translational studies and became the founding director of TRC. He is also in charge of the Medical Research Department of KMUH in the same year. Other than the above-mentioned administrative positions, he is also a full professor at KMU and adjunct professor at National Chiao-Tung University and National Sun Yat-sen University, Taiwan.
Prof. Duzgun OzatliProfessor
Prof. Duzgun Ozatli
Professor
2000 October - 2006 July Hematology and Blood Bank Specialist at Dışkapı SSK Training Hospital and Specialization Hospital, 2006 July- present Ondokuz Mayis Medical Faculty, Hematology Department, Samsun, Turkey. Member of Turkish Society of Internal Diseases Turkish Hematology Association.
Kakil Ibrahim RasulCABM, FRCP, ESMO
Kakil Ibrahim Rasul
CABM, FRCP, ESMO
Weill Cornell Medical College
Senior consultant in Haem/ Oncology at NCCCR, Hamad Medical Corporation Doha, Qatar. Associate Prof. in clinical medicine at Weil Cornell Medical College in Qatar.
Co-ordinator the medical education NCCCR, Hamad Medical Corporation. Leading the Hepatobiliary pancreatic Multidisciplinary team Hamad Medical Corporation, Core Member of the Gastrointestinal Multidisciplinary team, Hamad Medical Corporation. The active member of ESMO, ASCO, EHA. Core member of both colorectal hepatobiliary MENA-NCCN guidelines panels for development of the guideline modifications Reviewer for many journals; Saudi Medical Journal, Qatar Medical Journal, Annals of Saudi Medicine. Editorial Board Member Journal of Hepatology Research, Advanced Modern Oncology Research, Educational book of ASCO 2018.
Welcome to International Conference on Cancer Research & Treatment 2019
MomentEra is glad to welcome you all to the International Conference on Cancer Research & Treatment 2019 which will be held during March 25th - 26th, 2019 in Bangkok, Thailand.
Here is a chance for you to be a part of one the biggest international event in the field of Cancer Research & Treatment During this event, you will have a great chance to socialize with other researchers, scientists, professors, and students in the field of Cancer Research & Treatment. You should be able to discover novel opportunities and broaden your knowledge through this professional event. It will also serve as a great platform for participants for research Philomath’s to exchange and share their experiences and research results about all aspects of Cancer Research & Treatment.
It withal provides the premier interdisciplinary forum for researchers, practitioners, and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the field of Cancer Research & Treatment.
The main theme of the International Conference on Cancer Research & Treatment 2019 is “Mission and Innovation to Eradicate Cancer“.
International Conference on Cancer Research & Treatment 2019 is anticipating around the globe and the two-day conference will include plenary sessions, keynote speeches, poster, and oral presentations.
Event Venue
Novotel Sukhumvit 20 – Bangkok
The new Novotel Bangkok Sukhumvit 20 offers all the superb facilities, exemplary service, and luxuries of one of the finest hotels in Bangkok.
Centrally located in the heart of Sukhumvit, Bangkok's most vibrant district and only 30 minutes' drive from Suvarnabhumi International Airport, it is surrounded by all the life, excitement and energy that the city is famed for, and within easy walking distance of many attractions including Bangkok's newest shopping district, the EmQuartier, the upmarket Emporium Department Store, the Dinosaur Planet Theme Park , Asok BTS and Sukhumvit MRT public transportation stations, and the Airport Rail Link.
Each of the hotel's 244 rooms perfectly blends clean modern lines and traditional Thai style, allowing you to unwind in an atmosphere of unmatched calm and relaxation. All rooms feature the fullest range of contemporary comforts, including complimentary Wi-Fi, modern furnishings, large LCD TVs and bright, stylish, bathrooms.
Dining options, which offer something to suit every taste, include the "Gourmet Bar" and "Food Exchange," Novotel's latest dining concepts that serve superb local and international cuisine, and "Sky on 20," our rooftop bar on the 26th Floor, the perfect venue to round off the evening with a nightcap while taking in the colors and lights of the Bangkok nightscape, (opening soon). The hotel's meeting facilities are perfect for every type of occasion, and offer cutting edge technical equipment and a professional planning and catering service.
They include a Large Ballroom with natural daylight for up to 1000 people, 6 additional Meeting Rooms, and 3 private Dining Rooms across three floors of function space. The friendly and dedicated staff at the Novotel Bangkok Sukhumvit 20 look forward to welcoming you, and to ensure that you receive the impeccable service and comfort that every Novotel is known for around the world!
Centrally located in the heart of Sukhumvit, Bangkok's most vibrant district and only 30 minutes' drive from Suvarnabhumi International Airport, it is surrounded by all the life, excitement and energy that the city is famed for, and within easy walking distance of many attractions including Bangkok's newest shopping district, the EmQuartier, the upmarket Emporium Department Store, the Dinosaur Planet Theme Park , Asok BTS and Sukhumvit MRT public transportation stations, and the Airport Rail Link.
Each of the hotel's 244 rooms perfectly blends clean modern lines and traditional Thai style, allowing you to unwind in an atmosphere of unmatched calm and relaxation. All rooms feature the fullest range of contemporary comforts, including complimentary Wi-Fi, modern furnishings, large LCD TVs and bright, stylish, bathrooms.
Dining options, which offer something to suit every taste, include the "Gourmet Bar" and "Food Exchange," Novotel's latest dining concepts that serve superb local and international cuisine, and "Sky on 20," our rooftop bar on the 26th Floor, the perfect venue to round off the evening with a nightcap while taking in the colors and lights of the Bangkok nightscape, (opening soon). The hotel's meeting facilities are perfect for every type of occasion, and offer cutting edge technical equipment and a professional planning and catering service.
They include a Large Ballroom with natural daylight for up to 1000 people, 6 additional Meeting Rooms, and 3 private Dining Rooms across three floors of function space. The friendly and dedicated staff at the Novotel Bangkok Sukhumvit 20 look forward to welcoming you, and to ensure that you receive the impeccable service and comfort that every Novotel is known for around the world!
Scientific Sessions / Tracks
- Lung Cancer/pulmonary or Thoracic cancer
- Living with & Beyond cancer
- Development of health care delivery methods for cancer
- Cellular & Genetically Mechanisms of Ontogenesis
- Organ Specific cancer
- Causes of cancer
- Cancer Basics
- Cancer Epidemiology
- Treatment/Diagnosis
- Prevention
- Early diagnostics and imagery
- Cancer due to Obesity
- Role of Stem Cell in Cancer Therapy
- Cancer Stem Cells, trials and translations
- The choice of source of Stem Cells for Cancer Therapy
- Surgery
- Radiotherapy
- Chemotherapy
- New biomarkers
- Carcinogenesis
- Research and Development of Cancer
- Novel Cancer Drugs and its Pharmacology
- Photon Therapy
- Neutron Capture Therapy
- Boron Neutron Capture Therapy (BNCT)
- Gadolinium Neutron Capture Therapy (GdNCT)
- Interventional radiology
- Photo Biomodulation in Cancer Therapy
- Stem Cell Transplant for Cancer - Allogeneic & Autologous
- Immune Cells in Cancer Therapy and Drug Delivery
- T-Cell Therapy to Treat Cancer
